Healthcare

Gilead is a biopharma leader anchored by a powerful HIV franchise, rising revenue momentum, and substantial cash generation. The key question is whether oncology, cell therapy, and long-acting medicines can grow into a broader second engine.

CVS Health combines insurance, pharmacy benefits, retail pharmacy, and care delivery at national scale. The article examines how that breadth supports durable revenue, why cash flow remains a key strength, and what still needs to improve for earnings quality.

Danaher supplies essential tools for biotech production, lab research, and diagnostics. Strong margins, recurring consumables revenue, and a disciplined portfolio strategy make it a closely watched healthcare franchise as growth gradually recovers.

Bristol-Myers Squibb is a global drugmaker anchored in cancer, immunology, and cardiovascular medicines. Strong cash flow, high margins, and a growing group of newer products make its transition beyond older blockbusters worth a closer look.

Abbott is a diversified healthcare leader spanning devices, diagnostics, nutrition, and branded medicines. The strongest angle is its expanding diabetes platform, supported by solid profitability, broad global reach, and steady cash generation.